IT1181682B - Impiego di alcanoil l-carnitine per il trattamento terapeutico del parkinsonismo idiopatico o indotto - Google Patents

Impiego di alcanoil l-carnitine per il trattamento terapeutico del parkinsonismo idiopatico o indotto

Info

Publication number
IT1181682B
IT1181682B IT48206/85A IT4820685A IT1181682B IT 1181682 B IT1181682 B IT 1181682B IT 48206/85 A IT48206/85 A IT 48206/85A IT 4820685 A IT4820685 A IT 4820685A IT 1181682 B IT1181682 B IT 1181682B
Authority
IT
Italy
Prior art keywords
idiopathic
carnitine
alcanoil
therapeutic treatment
induced parkinsonism
Prior art date
Application number
IT48206/85A
Other languages
English (en)
Other versions
IT8548206A0 (it
Inventor
Marco Onofrj
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT48206/85A priority Critical patent/IT1181682B/it
Publication of IT8548206A0 publication Critical patent/IT8548206A0/it
Priority to US06/869,083 priority patent/US4663352A/en
Priority to DE8686830150T priority patent/DE3686520T2/de
Priority to AT86830150T priority patent/ATE79749T1/de
Priority to EP86830150A priority patent/EP0207011B1/en
Priority to JP61135868A priority patent/JPH0684298B2/ja
Application granted granted Critical
Publication of IT1181682B publication Critical patent/IT1181682B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
IT48206/85A 1985-06-11 1985-06-11 Impiego di alcanoil l-carnitine per il trattamento terapeutico del parkinsonismo idiopatico o indotto IT1181682B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT48206/85A IT1181682B (it) 1985-06-11 1985-06-11 Impiego di alcanoil l-carnitine per il trattamento terapeutico del parkinsonismo idiopatico o indotto
US06/869,083 US4663352A (en) 1985-06-11 1986-05-30 Use of some alkanoyl L-carnitines for the therapeutical treatment of idiopathic and induced Parkinsonism
DE8686830150T DE3686520T2 (de) 1985-06-11 1986-06-03 Verwendung von einigen alkanoyl-l-carnitinen zur herstellung eines arzneimittels zur therapeutischen behandlung von ideopathischem oder induziertem parkinsonismus.
AT86830150T ATE79749T1 (de) 1985-06-11 1986-06-03 Verwendung von einigen alkanoyl-l-carnitinen zur herstellung eines arzneimittels zur therapeutischen behandlung von ideopathischem oder induziertem parkinsonismus.
EP86830150A EP0207011B1 (en) 1985-06-11 1986-06-03 Use of some alkanoyl l-carnitines for the manufacture of a medicament for therapeutical treatment of idiopathic and induced parkinsonism
JP61135868A JPH0684298B2 (ja) 1985-06-11 1986-06-10 パ−キンソン病治療薬

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48206/85A IT1181682B (it) 1985-06-11 1985-06-11 Impiego di alcanoil l-carnitine per il trattamento terapeutico del parkinsonismo idiopatico o indotto

Publications (2)

Publication Number Publication Date
IT8548206A0 IT8548206A0 (it) 1985-06-11
IT1181682B true IT1181682B (it) 1987-09-30

Family

ID=11265224

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48206/85A IT1181682B (it) 1985-06-11 1985-06-11 Impiego di alcanoil l-carnitine per il trattamento terapeutico del parkinsonismo idiopatico o indotto

Country Status (6)

Country Link
US (1) US4663352A (it)
EP (1) EP0207011B1 (it)
JP (1) JPH0684298B2 (it)
AT (1) ATE79749T1 (it)
DE (1) DE3686520T2 (it)
IT (1) IT1181682B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1208753B (it) * 1986-07-02 1989-07-10 Sigma Tau Ind Farmaceuti L-amminoacil derivati della l-carnitina, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' epatoprotettrice che li contengono
IT1224842B (it) * 1988-12-27 1990-10-24 Sigma Tau Ind Farmaceuti Uso di derivati della l-carnitina nel trattamento terapeutico delle alterazioni degenerative del sistema nervoso
US5641764A (en) * 1989-03-31 1997-06-24 Peter Maccallum Institute Halogenated DNA ligand radiosensitizers for cancer therapy
IT1245699B (it) * 1991-05-29 1994-10-14 Sigma Tau Ind Farmaceuti Derivati della l-carnitina quali agenti terapeutici per il trattamento delle miopatie, della degenarazione neuronale e per inibire la proteolisi
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1284661B1 (it) * 1996-06-06 1998-05-21 Sigma Tau Ind Farmaceuti Uso di alcanoil l-carnitine nel trattamento terapeutico di malattie infiammatorie croniche intestinali.
IT1305308B1 (it) * 1999-03-26 2001-05-04 Biosint S P A Granulato ad alto contenuto di l-carnitina o alcanoil-l-carnitina,particolarmente adatto alla produzione di compresse per compressione
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US20060252775A1 (en) * 2005-05-03 2006-11-09 Henderson Samuel T Methods for reducing levels of disease associated proteins
KR101170266B1 (ko) 2008-05-30 2012-08-01 케이씨아이 라이센싱 인코포레이티드 감압으로 선형적인 상처를 폐쇄하는 볼스터 및 시스템
AU2009262881B2 (en) 2008-05-30 2013-05-23 Solventum Intellectual Properties Company Reduced-pressure, compression systems and apparatuses for use on a curved body part
EP2586438A1 (en) 2011-10-28 2013-05-01 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Compound useful for preventing cognitive deficit disorders in a new born from HIV-seropositive pregnant female who is in treatment with azidothymidine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
IT1206954B (it) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche
IT1150396B (it) * 1982-12-09 1986-12-10 Sigma Tau Ind Farmaceuti Impiego di alcanoil l-carnitine per il trattamento terapeutico di miopa tie e distrofie muscolari
US4537772A (en) * 1984-05-02 1985-08-27 Merck & Co., Inc. Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines

Also Published As

Publication number Publication date
US4663352A (en) 1987-05-05
DE3686520D1 (de) 1992-10-01
JPH0684298B2 (ja) 1994-10-26
EP0207011A3 (en) 1989-11-29
EP0207011A2 (en) 1986-12-30
DE3686520T2 (de) 1993-02-18
ATE79749T1 (de) 1992-09-15
EP0207011B1 (en) 1992-08-26
IT8548206A0 (it) 1985-06-11
JPS61286326A (ja) 1986-12-16

Similar Documents

Publication Publication Date Title
MX171191B (es) Composiciones farmaceuticas de glipizida
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
MX9203543A (es) Medicamento.
ES2039262T3 (es) Uso de acetil l-carnitina para la preparacion de un medicamento para el tratamiento terapeutico de neuropatias perifericas.
ATE129404T1 (de) Dosierungsform fuer die freisetzung eines witkstoffs in einem kurzen zeitraum.
ATE157257T1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
DE3779500T2 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
GR3025502T3 (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals.
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
ES2066790T3 (es) Formulaciones farmaceuticas para evitar la tolerancia a medicamentos.
IT1181682B (it) Impiego di alcanoil l-carnitine per il trattamento terapeutico del parkinsonismo idiopatico o indotto
ES2173111T3 (es) Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos.
DK0876152T3 (da) Hidtil ukendt administrering af thrombopoietin
KR950007848A (ko) (S)-(-)-α-에틸-2-옥소-1-피롤리딘아세트아미드를 사용한 불안치료방법
ES2070478T3 (es) El empleo de acetil l-carnitina en el tratamiento terapeutico de coma.
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
BE867396A (fr) Nouveau medicament utile dans le traitement des affections bacteriennes
KR900009029A (ko) 가축병 치료용 약물을 투여하는 장치
DE3688787D1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
KR910009280A (ko) 원발성 흉막암 치료용 제약 조성물의 제조에 있어서 감마 인터페론 활성을 갖는 폴리펩티드의 용도
FR2645747B1 (fr) Nouvelles compositions pharmaceutiques, leur procede d'obtention et leur emploi en therapeutique tumorale
RU94002713A (ru) Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда)
GB2144410A (en) Therapeutic application of an imidazo (2,1a) isoindole derivative
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
RU94037731A (ru) Способ лечения рассеянного склероза

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970515